Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis: a real-life cohort study

BACKGROUND: There have been few real-life dose-comparing studies on the efficacy and safety of secukinumab in Chinese patients with plaque psoriasis. We conducted a real-life cohort study to investigate the efficacy and safety of secukinumab 150 and 300 mg in Chinese patients with moderate-to-severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan, Cai, Lin, Liu, Xiao-Yang, Zhang, Heng, Zhang, Jian-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183798/
https://www.ncbi.nlm.nih.gov/pubmed/33950871
http://dx.doi.org/10.1097/CM9.0000000000001510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183798/
https://www.ncbi.nlm.nih.gov/pubmed/33950871
http://dx.doi.org/10.1097/CM9.0000000000001510

Ejemplares similares